Viatris Inc. is recalling 6,789 bottles of alprazolam XR (Xanax XR) 3 mg extended-release tablets because the medication failed dissolution testing. This means the tablets may not release the active ingredient into the body as intended, which could make the treatment less effective. The 60-count bottles were distributed nationwide by Greenstone LLC and were sold with lot number EH8348 and an expiration date of August 2023.
Low dissolution results mean the medication may not break down and release correctly in the body, potentially resulting in a patient not receiving the full intended dose of the drug. No injuries or adverse events have been reported to date.
You have 2 options:
Distributed by Greenstone LLC; Recall #: D-0844-2022
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.